Simplex Trading
NXTC icon

Simplex Trading’s NextCure NXTC Stock Holding History

Simplex Trading’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-108
Closed -$2K – 9240
2024
Q2 		$2K Buy
+108
New +$2.1K ﹤0.01% 8320
2022
Q4 		– Sell
-267
Closed -$8K – 10043
2022
Q3 		$8K Hold
267
– – ﹤0.01% 8419
2022
Q2 		$15K Buy
+267
New +$13.9K ﹤0.01% 7885
2021
Q4 		– Sell
-58
Closed -$5K – 11127
2021
Q3 		$5K Hold
58
– – ﹤0.01% 9277
2021
Q2 		$5K Buy
+58
New +$5.93K ﹤0.01% 9463
2021
Q1 		– Sell
-1
Closed -$14K – 9665
2020
Q4 		$14K Hold
1
– – ﹤0.01% 7206
2020
Q3 		$7K Sell
1
-1
-50% -$123 ﹤0.01% 6962
2020
Q2 		$62K Hold
2
– – ﹤0.01% 5298
2020
Q1 		$107K Sell
2
-1
-33% -$534 ﹤0.01% 4300
2019
Q4 		$230K Buy
+3
New +$1.5K ﹤0.01% 3600

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NXTC Position: Q3 2025 in Review

Simplex Trading sold out of NextCure (NXTC) in Q3 2025, closing a stake of 77 shares.

Simplex Trading first reported a position in NXTC in Q4 2019 and held it in 10 quarters. The position peaked at $69K in Q4 2019. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Simplex Trading reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 77 NextCure shares in Q3 2025.
  • Simplex Trading first reported a position in NextCure in Q4 2019 and held it in 10 quarters.
  • Simplex Trading's NextCure position peaked at $69K in Q4 2019.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.